TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Ward, E. AU - Hao, Y. AU - Xu, J. AU - Thun, M. J. PY - 2009 DA - 2009// TI - Cancer statistics, 2009 JO - CA Cancer J Clin VL - 59 UR - https://doi.org/10.3322/caac.20006 DO - 10.3322/caac.20006 ID - Jemal2009 ER - TY - JOUR AU - Zelefsky, M. J. AU - Fuks, Z. AU - Leibel, S. A. PY - 2002 DA - 2002// TI - Intensity-modulated radiation therapy for prostate cancer JO - Semin Radiat Oncol VL - 12 UR - https://doi.org/10.1053/srao.2002.00000 DO - 10.1053/srao.2002.00000 ID - Zelefsky2002 ER - TY - JOUR AU - Leibel, S. A. AU - Fuks, Z. AU - Zelefsky, M. J. AU - Wolden, S. L. AU - Rosenzweig, K. E. AU - Alektiar, K. M. AU - Hunt, M. A. AU - Yorke, E. D. AU - Hong, L. X. AU - Amols, H. I. AU - Burman, C. M. AU - Jackson, A. AU - Mageras, G. S. AU - LoSasso, T. AU - Happersett, L. AU - Spirou, S. V. AU - Chui, C. S. AU - Ling, C. C. PY - 2002 DA - 2002// TI - Intensity-modulated radiotherapy JO - Cancer J VL - 8 UR - https://doi.org/10.1097/00130404-200203000-00010 DO - 10.1097/00130404-200203000-00010 ID - Leibel2002 ER - TY - JOUR AU - Perez, C. A. AU - Michalski, J. M. AU - Purdy, J. A. AU - Lockett, M. A. PY - 2000 DA - 2000// TI - New trends in prostatic cancer research. Three-dimensional conformal radiation therapy (3-D CRT), brachytherapy, and new therapeutic modalities JO - Rays VL - 25 ID - Perez2000 ER - TY - JOUR AU - Nutting, C. M. AU - Convery, D. J. AU - Cosgrove, V. P. AU - Rowbottom, C. AU - Padhani, A. R. AU - Webb, S. AU - Dearnaley, D. P. PY - 2000 DA - 2000// TI - Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 48 UR - https://doi.org/10.1016/S0360-3016(00)00653-2 DO - 10.1016/S0360-3016(00)00653-2 ID - Nutting2000 ER - TY - JOUR AU - Bolla, M. AU - Gonzalez, D. AU - Warde, P. AU - Dubois, J. B. AU - Mirimanoff, R. O. AU - Storme, G. AU - Bernier, J. AU - Kuten, A. AU - Sternberg, C. AU - Gil, T. AU - Collette, L. AU - Pierart, M. PY - 1997 DA - 1997// TI - Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin JO - N Engl J Med VL - 337 UR - https://doi.org/10.1056/NEJM199707313370502 DO - 10.1056/NEJM199707313370502 ID - Bolla1997 ER - TY - JOUR AU - Pilepich, M. V. AU - Krall, J. M. AU - Al-Sarraf, M. AU - John, M. J. AU - Doggett, R. L. AU - Sause, W. T. AU - Lawton, C. A. AU - Abrams, R. A. AU - Rotman, M. AU - Rubin, P. AU - Shipley, W. U. AU - Grignon, D. AU - Caplan, R. AU - Cox, J. D. AU - Soloway, M. S. PY - 1995 DA - 1995// TI - Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the Radiation Therapy Oncology Group JO - Urology VL - 45 UR - https://doi.org/10.1016/S0090-4295(99)80053-3 DO - 10.1016/S0090-4295(99)80053-3 ID - Pilepich1995 ER - TY - JOUR AU - Catalona, W. J. AU - Smith, D. S. AU - Ratliff, T. L. AU - Dodds, K. M. AU - Coplen, D. E. AU - Yuan, J. J. AU - Petros, J. A. AU - Andriole, G. L. PY - 1991 DA - 1991// TI - Measurement of prostate-specific antigen in serum as a screening test for prostate cancer JO - N Engl J Med VL - 324 UR - https://doi.org/10.1056/NEJM199104253241702 DO - 10.1056/NEJM199104253241702 ID - Catalona1991 ER - TY - JOUR AU - Hudson, M. A. AU - Bahnson, R. R. AU - Catalona, W. J. PY - 1989 DA - 1989// TI - Clinical use of prostate specific antigen in patients with prostate cancer JO - J Urol VL - 142 ID - Hudson1989 ER - TY - JOUR PY - 1997 DA - 1997// TI - Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel JO - Int J Radiat Oncol Biol Phys VL - 37 ID - ref10 ER - TY - JOUR AU - Roach, M. AU - Hanks, G. AU - Thames, H. AU - Schellhammer, P. AU - Shipley, W. U. AU - Sokol, G. H. AU - Sandler, H. PY - 2006 DA - 2006// TI - Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference JO - Int J Radiat Oncol Biol Phys VL - 65 UR - https://doi.org/10.1016/j.ijrobp.2006.04.029 DO - 10.1016/j.ijrobp.2006.04.029 ID - Roach2006 ER - TY - JOUR AU - Miller, J. I. AU - Ahmann, F. R. AU - Drach, G. W. AU - Emerson, S. S. AU - Bottaccini, M. R. PY - 1992 DA - 1992// TI - The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer JO - J Urol VL - 147 ID - Miller1992 ER - TY - JOUR AU - Pretlow, T. G. AU - Pretlow, T. P. AU - Yang, B. AU - Kaetzel, C. S. AU - Delmoro, C. M. AU - Kamis, S. M. AU - Bodner, D. R. AU - Kursh, E. AU - Resnick, M. I. AU - Bradley, E. L. PY - 1991 DA - 1991// TI - Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia JO - Int J Cancer VL - 49 UR - https://doi.org/10.1002/ijc.2910490503 DO - 10.1002/ijc.2910490503 ID - Pretlow1991 ER - TY - JOUR AU - Magklara, A. AU - Scorilas, A. AU - Stephan, C. AU - Kristiansen, G. O. AU - Hauptmann, S. AU - Jung, K. AU - Diamandis, E. P. PY - 2000 DA - 2000// TI - Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue JO - Urology VL - 56 UR - https://doi.org/10.1016/S0090-4295(00)00621-X DO - 10.1016/S0090-4295(00)00621-X ID - Magklara2000 ER - TY - JOUR AU - Riegman, P. H. AU - Vlietstra, R. J. AU - van der Korput, J. A. AU - Brinkman, A. O. AU - Trapman, J. PY - 1991 DA - 1991// TI - The promoter of the prostate-specific antigen gene contains a functional androgen responsive element JO - Mol Endocrinol VL - 5 UR - https://doi.org/10.1210/mend-5-12-1921 DO - 10.1210/mend-5-12-1921 ID - Riegman1991 ER - TY - JOUR AU - Cleutjens, K. B. AU - van Eekelen, C. C. AU - van der Korput, H. A. AU - Brinkman, A. O. AU - Trapman, J. PY - 1996 DA - 1996// TI - Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter JO - J Biol Chem VL - 271 UR - https://doi.org/10.1074/jbc.271.11.6379 DO - 10.1074/jbc.271.11.6379 ID - Cleutjens1996 ER - TY - JOUR AU - Collette, L. AU - Burzykowski, T. AU - Carroll, K. J. AU - Newling, D. AU - Morris, T. AU - Schroder, F. H. PY - 2005 DA - 2005// TI - Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? Joint research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals JO - J Clin Onc VL - 23 UR - https://doi.org/10.1200/JCO.2005.08.156 DO - 10.1200/JCO.2005.08.156 ID - Collette2005 ER - TY - JOUR AU - Chung, C. S. AU - Chen, M. -. H. AU - Cullen, J. AU - McLeod, D. AU - Carroll, P. AU - D'Amico, A. V. PY - 2008 DA - 2008// TI - Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality JO - Urology VL - 71 UR - https://doi.org/10.1016/j.urology.2007.08.028 DO - 10.1016/j.urology.2007.08.028 ID - Chung2008 ER - TY - JOUR AU - Ray, M. E. AU - Thames, H. D. AU - Levy, L. B. AU - Horwitz, E. M. AU - Kupelian, P. A. AU - Martinez, A. A. AU - Michalski, J. M. AU - Pisansky, T. M. AU - Shipley, W. U. AU - Zelefsky, M. J. AU - Zietman, A. L. AU - Kuban, D. A. PY - 2006 DA - 2006// TI - PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: A multi-institutional analysis JO - Int J Radiat Oncol Biol Phys VL - 64 UR - https://doi.org/10.1016/j.ijrobp.2005.07.006 DO - 10.1016/j.ijrobp.2005.07.006 ID - Ray2006 ER - TY - CHAP AU - Hori, S. AU - Jabbar, T. AU - Kachroo, N. AU - Vasconcelos, J. C. AU - Robson, C. N. AU - Gnanapragasam, V. J. PY - 2010 DA - 2010// TI - Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancer BT - J Cancer Res Clin Oncol ID - Hori2010 ER - TY - JOUR AU - Crook, J. AU - Ludgate, C. AU - Malone, S. AU - Perry, G. AU - Eapen, L. AU - Bowen, J. AU - Robertson, S. AU - Lockwood, G. PY - 2009 DA - 2009// TI - Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer JO - Int J Radiat Oncol Biol Phys VL - 73 UR - https://doi.org/10.1016/j.ijrobp.2008.04.075 DO - 10.1016/j.ijrobp.2008.04.075 ID - Crook2009 ER - TY - JOUR AU - Zapatero, A. AU - Valcarcel, F. AU - Calvo, F. A. AU - Algas, R. AU - Bejar, A. AU - Maldonado, J. AU - Villa, S. PY - 2005 DA - 2005// TI - Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.09.662 DO - 10.1200/JCO.2005.09.662 ID - Zapatero2005 ER - TY - JOUR AU - Pilepich, M. V. AU - Winter, K. AU - Lawton, C. A. AU - Krisch, R. E. AU - Wolkov, H. B. AU - Movsas, B. AU - Hug, E. B. AU - Asbell, S. O. AU - Grignon, D. PY - 2005 DA - 2005// TI - Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-long-term results of phase III RTOG 85-31 JO - Int J Radiat Oncol Biol Phys VL - 61 UR - https://doi.org/10.1016/j.ijrobp.2004.08.047 DO - 10.1016/j.ijrobp.2004.08.047 ID - Pilepich2005 ER -